CMA
Aspen Pharmacare to pay £8 million after colluding to rip off NHS
August 14, 2019Research and Development Addison's disease, Aspen Pharmacare, CMA, NHS, pharma
South African firm Aspen Pharmacare has agreed to pay £8 million to Britain’s NHS over a dispute about overpayment. The …
NHS faced with 5,700% increase in drug price, finds CMA
November 21, 2017Manufacturing and Production, Medical Communications CMA, Concordia, biotech, drugs, pharma, pharmaceutical
The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …
Regulators get aggressive on matters excessive
June 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen
Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …
CMA accuses Concordia and Actavis of illegal agreement to maintain high prices
March 3, 2017Medical Communications, Sales and Marketing Actavis UK, CMA, Concordia, competition and markets authority
The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …
Actavis UK overcharged NHS with 12,000% price hike, watchdog says
December 16, 2016Medical Communications, Sales and Marketing Actavis, CMA, NHS
Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …
Pfizer slapped with record £84.2 million fine for 2,600% price increase
December 7, 2016Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine
Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
Pfizer fined for epilepsy drug price increase by UK antitrust regulator
April 15, 2016Medical Communications CMA, Flynn Pharma, Pfizer, antitrust, competition and markets authority, epilepsy, fine, flynn
Pfizer has been fined for unfairly increasing the price of epilepsy drug Epanutin (phenytoin sodium) by the UK Competition and …
Pfizer and Flynn rapped for overcharging on anti-epilepsy drug
August 6, 2015Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing
Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …
